BMS-986278, an Oral Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist, for Patients With Idiopathic Pulmonary Fibrosis: Results From a Phase 2 Randomized Trial
T.J. Corte, Vincent Cottin, Marilyn K. Glassberg, M. Kreuter, Takashi Ogura, T. Suda, J.G. Goldin, E. Berkowitz, B. Elpers, Su Hui Kim, G.S. Tirucherai, Hideaki Watanabe, Aryeh Fischer, Toby M. Maher
Topics & Concepts
Lysophosphatidic acidAntagonistMedicineInternal medicineReceptor antagonistRandomized controlled trialPhase (matter)GastroenterologyReceptorPharmacologyChemistryOrganic chemistryInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisPI3K/AKT/mTOR signaling in cancerLung Cancer Treatments and Mutations